Skip to content

Main Navigation

Clinical Study

TREO PAS

You may decide to volunteer. You are free to decide to join this research or not to join this research. You may be asked to take part in this research if your doctor feels that you may be a good candidate to be treated with the TREO Abdominal Stent-Graft. The Food and Drug Administration (FDA) has approved this TREO medical device to treat abdominal aortic aneurysms (AAA) for endovascular (EVAR) (not open) surgeries. The purpose of this research is to help determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with AAA. After your EVAR repair with the TREO Abdominal Stent-Graft, you will return to your doctor for 1-month and 12-month follow-up visits. Following the 12-month follow-up, you will return once a year for 5 years. Patients who enroll will do 8 visits in total over 5 years. There is no randomization or blinding the treatment. All eligible patients who can have EVAR surgery and TREO Abdominal Stent-Graft to treat AAA are welcome to join.

I AM INTERESTED

For more information contact:

Julie Beckstrom

  julie.beckstrom@hsc.utah.edu
  801-587-1450

IRB#: IRB_00138928 | PI: Claire Griffin | Department: Vascular Surgery Division | Approval Date: 2021-04-07 06:00:00
Study Categories: Heart Studies | Specialties: Surgery, General, Vascular Surgery

Who can participate?

 Gender: All

 Age: Over 18 years old

 Volunteers: Volunteers with special conditions

 Location: In Person


Will I be paid for my time?

Yes

Last Updated: 8/23/22